- ACTIVE INGREDIENT
- USES
-
WARNINGS
FOR EXTERNAL USE ONLY
ASK DOCTOR OR PHARMACIST BEFORE USE IF YOU ARE
USING OTHER TOPICAL ACNE MEDICATIONS AT THE SAME TIME OR IMMEDIATELY FOLLOWING USE OF THIS PRODUCT. THIS MAY INCREASE DRYNESS OR IRRITATION OF THE SKIN. IF THIS OCCURS, ONLY ONE MEDICATION SHOULD BE USED UNLESS OTHERWISE DIRECTED BY A DOCTOR
- DIRECTIONS
- OTHER INFORMATION
-
INACTIVE INGREDIENTS
WATER (AQUA), SODIUM C14-16 OLEFIN SULFONATE, GLYCERIN, COCAMIDOPROPYL BETAINE, OXIDIZED POLYETHYLENE, ACRYLATES CROSSPOLYMER-4, CHONDRUS CRISPUS (CARRAGEENAN) POWDER, C12-15 ALKYL LACTATE, DISODIUM EDTA, COCAMIDOPROPYL PG-DIMONIUM CHLORIDE PHOSPHATE, CITRUS GRANDIS (GRAPEFRUIT) FRUIT EXTRACT, POLYQUATERNIUM-7, CAMELLIA SINENSIS LEAF EXTRACT, ASCORBYL PALMITATE, NEOPENTYL GLYCOL DICAPRYLATE/DICAPRATE, ANTHEMIS NOBILIS FLOWER EXTRACT, POLYSORBATE 20, POLYVINYL ALCOHOL, PROPYLENE GLYCOL, SODIUM CHLORIDE, BUTYLENE GLYCOL, SODIUM BENZOTRIAZOLYL BUTYLPHENOL SULFONATE, AGAR, MICA, TITANIUM DIOXIDE (CI 77891), SODIUM HYDROXIDE, RED 30 (CI 73360), RED 40 (CI 16035), EXT. VIOLET 2 (CI 60730), FRAGRANCE (PARFUM)
- QUESTIONS/COMMENTS?
- LABEL COPY
-
INGREDIENTS AND APPEARANCE
WALGREENS PINK GRAPEFRUIT
salicylic acid liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:0363-0828 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID 20 mg in 1 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) SODIUM C14-16 OLEFIN SULFONATE (UNII: O9W3D3YF5U) GLYCERIN (UNII: PDC6A3C0OX) COCAMIDOPROPYL BETAINE (UNII: 5OCF3O11KX) HIGH DENSITY POLYETHYLENE (UNII: UG00KM4WR7) CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: 71DD5V995L) CHONDRUS CRISPUS (UNII: OQS23HUA1X) C12-15 ALKYL LACTATE (UNII: GC844VRD7E) EDETATE DISODIUM (UNII: 7FLD91C86K) COCAMIDOPROPYL PG-DIMONIUM CHLORIDE PHOSPHATE (UNII: H2KVQ74JM4) PUMMELO (UNII: ET1TN5W71X) POLYQUATERNIUM-7 (70/30 ACRYLAMIDE/DADMAC; 1600000 MW) (UNII: 0L414VCS5Y) GREEN TEA LEAF (UNII: W2ZU1RY8B0) ASCORBYL PALMITATE (UNII: QN83US2B0N) NEOPENTYL GLYCOL DICAPRYLATE/DICAPRATE (UNII: VLW429K27K) CHAMAEMELUM NOBILE FLOWER (UNII: O2T154T6OG) POLYSORBATE 20 (UNII: 7T1F30V5YH) POLYVINYL ALCOHOL (UNII: 532B59J990) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) SODIUM CHLORIDE (UNII: 451W47IQ8X) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) SODIUM BENZOTRIAZOLYL BUTYLPHENOL SULFONATE (UNII: 0LA2QC9O3Z) AGAR (UNII: 89T13OHQ2B) MICA (UNII: V8A1AW0880) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) SODIUM HYDROXIDE (UNII: 55X04QC32I) D&C RED NO. 30 (UNII: 2S42T2808B) FD&C RED NO. 40 (UNII: WZB9127XOA) EXT. D&C VIOLET NO. 2 (UNII: G5UX3K0728) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:0363-0828-04 125 mL in 1 TUBE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part333D 12/17/2013 Labeler - WALGREEN COMPANY (008965063) Registrant - APOLLO HEALTH AND BEAUTY CARE (201901209) Establishment Name Address ID/FEI Business Operations APOLLO HEALTH AND BEAUTY CARE 201901209 manufacture(0363-0828)